Yama A. Abassi joined ACEA Biosciences in 2003 to help develop a new technology for studying cells using microelectronics. His efforts in this field have earned him numerous publications and patents and have led to the successful development and commercialization of the xCELLigence Real-Time Cell Analysis (RTCA) instrument globally.
Dr. Abassi continues to pursue his research interests in developing technologies and applications for in vitro cell-based assays in different fields, including cancer immunotherapy. He also oversees several collaborations with the US EPA that focus on assessing the impact of toxic environmental compounds (in particular, compounds which may interfere with estrogen signaling pathways).
He received his undergraduate degree in biochemistry with honors from the State University of New York/Stony Brook in 1992, and a Ph.D. in Molecular, Cell, and Developmental Biology from the University of California at Santa Barbara in 1999. Dr. Abassi joined the Burnham Institute for Cancer Research as an NIH post-doctoral fellow in 1999 and spent the next few years studying oncogene signaling pathways and their role in cancer biology.
read more